Genital Herpes simplex virus Type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease

Briana Nixon, Esra Fakioglu, Martha Stefanidou, Yanhua Wang, Monica Dutta, Harris Goldstein, Betsy Herold

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background. Epidemiological studies consistently demonstrate synergy between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1). Higher HIV-1 loads are observed in coinfected individuals, and conversely, HIV-1 is associated with more-severe herpetic disease. A small animal model of coinfection would facilitate identification of the biological mechanisms underlying this synergy and provide the opportunity to evaluate interventions.Methods. Mice transgenic for HIV-1 provirus and human cyclin T1 under the control of a CD4 promoter (JR-CSF/hu-cycT1) were intravaginally infected with HSV-2 and evaluated for disease progression, HIV shedding, and mucosal immune responses.Results. HSV-2 infection resulted in higher vaginal HIV loads and genital tissue expression of HIV RNA, compared with HSV-uninfected JR-CSF/hu-cycT1 mice. There was an increase in genital tract inflammatory cells, cytokines, chemokines, and interferons in response to HSV-2, although the kinetics of the response were delayed in HIV-transgenic, compared with control mice. Moreover, the JR-CSF/hu-cycT1 mice exhibited earlier and more-severe neurological disease. The latter was associated with downregulation of secretory leukocyte protease inhibitor expression in neuronal tissue, a molecule with antiinflammatory, antiviral, and neuroprotective properties.Conclusions. JR-CSF/hu-cycT1 mice provide a valuable model to study HIV/HSV-2 coinfection and identify potential mechanisms by which HSV-2 facilitates HIV-1 transmission and HIV modulates HSV-2-mediated disease.

Original languageEnglish (US)
Pages (from-to)510-522
Number of pages13
JournalJournal of Infectious Diseases
Volume209
Issue number4
DOIs
StatePublished - Feb 15 2014

Fingerprint

Herpes Genitalis
Human Herpesvirus 2
Transgenic Mice
HIV
HIV-1
Infection
Coinfection
Cyclin T
Secretory Leukocyte Peptidase Inhibitor
Proviruses
Mucosal Immunity
Virus Diseases
Chemokines
Interferons
Antiviral Agents
Disease Progression
Epidemiologic Studies
Anti-Inflammatory Agents
Down-Regulation
Animal Models

Keywords

  • coinfection
  • female genital tract
  • herpes simplex virus-2
  • human immunodeficiency virus-1
  • mouse model
  • sexually transmitted infections

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Genital Herpes simplex virus Type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease. / Nixon, Briana; Fakioglu, Esra; Stefanidou, Martha; Wang, Yanhua; Dutta, Monica; Goldstein, Harris; Herold, Betsy.

In: Journal of Infectious Diseases, Vol. 209, No. 4, 15.02.2014, p. 510-522.

Research output: Contribution to journalArticle

@article{4555855068954b16aad084dd7510bda6,
title = "Genital Herpes simplex virus Type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease",
abstract = "Background. Epidemiological studies consistently demonstrate synergy between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1). Higher HIV-1 loads are observed in coinfected individuals, and conversely, HIV-1 is associated with more-severe herpetic disease. A small animal model of coinfection would facilitate identification of the biological mechanisms underlying this synergy and provide the opportunity to evaluate interventions.Methods. Mice transgenic for HIV-1 provirus and human cyclin T1 under the control of a CD4 promoter (JR-CSF/hu-cycT1) were intravaginally infected with HSV-2 and evaluated for disease progression, HIV shedding, and mucosal immune responses.Results. HSV-2 infection resulted in higher vaginal HIV loads and genital tissue expression of HIV RNA, compared with HSV-uninfected JR-CSF/hu-cycT1 mice. There was an increase in genital tract inflammatory cells, cytokines, chemokines, and interferons in response to HSV-2, although the kinetics of the response were delayed in HIV-transgenic, compared with control mice. Moreover, the JR-CSF/hu-cycT1 mice exhibited earlier and more-severe neurological disease. The latter was associated with downregulation of secretory leukocyte protease inhibitor expression in neuronal tissue, a molecule with antiinflammatory, antiviral, and neuroprotective properties.Conclusions. JR-CSF/hu-cycT1 mice provide a valuable model to study HIV/HSV-2 coinfection and identify potential mechanisms by which HSV-2 facilitates HIV-1 transmission and HIV modulates HSV-2-mediated disease.",
keywords = "coinfection, female genital tract, herpes simplex virus-2, human immunodeficiency virus-1, mouse model, sexually transmitted infections",
author = "Briana Nixon and Esra Fakioglu and Martha Stefanidou and Yanhua Wang and Monica Dutta and Harris Goldstein and Betsy Herold",
year = "2014",
month = "2",
day = "15",
doi = "10.1093/infdis/jit472",
language = "English (US)",
volume = "209",
pages = "510--522",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Genital Herpes simplex virus Type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease

AU - Nixon, Briana

AU - Fakioglu, Esra

AU - Stefanidou, Martha

AU - Wang, Yanhua

AU - Dutta, Monica

AU - Goldstein, Harris

AU - Herold, Betsy

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Background. Epidemiological studies consistently demonstrate synergy between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1). Higher HIV-1 loads are observed in coinfected individuals, and conversely, HIV-1 is associated with more-severe herpetic disease. A small animal model of coinfection would facilitate identification of the biological mechanisms underlying this synergy and provide the opportunity to evaluate interventions.Methods. Mice transgenic for HIV-1 provirus and human cyclin T1 under the control of a CD4 promoter (JR-CSF/hu-cycT1) were intravaginally infected with HSV-2 and evaluated for disease progression, HIV shedding, and mucosal immune responses.Results. HSV-2 infection resulted in higher vaginal HIV loads and genital tissue expression of HIV RNA, compared with HSV-uninfected JR-CSF/hu-cycT1 mice. There was an increase in genital tract inflammatory cells, cytokines, chemokines, and interferons in response to HSV-2, although the kinetics of the response were delayed in HIV-transgenic, compared with control mice. Moreover, the JR-CSF/hu-cycT1 mice exhibited earlier and more-severe neurological disease. The latter was associated with downregulation of secretory leukocyte protease inhibitor expression in neuronal tissue, a molecule with antiinflammatory, antiviral, and neuroprotective properties.Conclusions. JR-CSF/hu-cycT1 mice provide a valuable model to study HIV/HSV-2 coinfection and identify potential mechanisms by which HSV-2 facilitates HIV-1 transmission and HIV modulates HSV-2-mediated disease.

AB - Background. Epidemiological studies consistently demonstrate synergy between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1). Higher HIV-1 loads are observed in coinfected individuals, and conversely, HIV-1 is associated with more-severe herpetic disease. A small animal model of coinfection would facilitate identification of the biological mechanisms underlying this synergy and provide the opportunity to evaluate interventions.Methods. Mice transgenic for HIV-1 provirus and human cyclin T1 under the control of a CD4 promoter (JR-CSF/hu-cycT1) were intravaginally infected with HSV-2 and evaluated for disease progression, HIV shedding, and mucosal immune responses.Results. HSV-2 infection resulted in higher vaginal HIV loads and genital tissue expression of HIV RNA, compared with HSV-uninfected JR-CSF/hu-cycT1 mice. There was an increase in genital tract inflammatory cells, cytokines, chemokines, and interferons in response to HSV-2, although the kinetics of the response were delayed in HIV-transgenic, compared with control mice. Moreover, the JR-CSF/hu-cycT1 mice exhibited earlier and more-severe neurological disease. The latter was associated with downregulation of secretory leukocyte protease inhibitor expression in neuronal tissue, a molecule with antiinflammatory, antiviral, and neuroprotective properties.Conclusions. JR-CSF/hu-cycT1 mice provide a valuable model to study HIV/HSV-2 coinfection and identify potential mechanisms by which HSV-2 facilitates HIV-1 transmission and HIV modulates HSV-2-mediated disease.

KW - coinfection

KW - female genital tract

KW - herpes simplex virus-2

KW - human immunodeficiency virus-1

KW - mouse model

KW - sexually transmitted infections

UR - http://www.scopus.com/inward/record.url?scp=84893305227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893305227&partnerID=8YFLogxK

U2 - 10.1093/infdis/jit472

DO - 10.1093/infdis/jit472

M3 - Article

C2 - 23990571

AN - SCOPUS:84893305227

VL - 209

SP - 510

EP - 522

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 4

ER -